Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients with Atrial Cardiopathy, The ARCADIA Randomized Clinical Trial
JAMA 331:573-581, Kamel,H.,et al, 2024
Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 384:970-971, , 2021
Acute Ischemic Stroke in Adolescents
Neurol 94:e158-e169, Rambaud, R.,et al, 2020
Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020
Ischemic Stroke and Internal Carotid Artery Web
Stroke 50:e31-e34, Mc Grory, B.,et al, 2019
Three Territory Sign
Neurol Clin Pract 9:124-128, Nouh, A.M.,et al, 2019
Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke?
BMJ 362:k2515, Kuijpers, T.,et al, 2018
Cardiac Magnetic Resonance Imaging: A New Tool to Identify Cardioaortic Sources in Ischaemic Stroke
JNNP 88:31-37, Yaghi, S.,et al, 2017
Prevention of Stroke in Patients with Silent Cerebrovascular Disease
Stroke 48:e44-e71, Smith, E.E.,et al, 2017
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017
Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017
Treatment of Cryptogenic Stroke with Active Cancer with a New Oral Anticoagulant
J Stroke Cerebrovasc Dis 26:2976-2980, Nam, K.W.,et al, 2017
Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice
Front Neurol 7:1-16, Nouh, A.,et al, 2016
Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016
Characteristics of Cryptogenic Stroke in Cancer Patients
Ann Clin Trans Neurol 3:280-287, Gon, Y.,et al, 2016
The Value of Transesophageal Echocardiography for Embolic Strokes of Undetermined Source
Neuol 87:988-995, Katsanos, A.H.,et al, 2016
Lambls Excrescense Associated with Cryptogenic Stroke
Am J Case Rep 16:876-881, Chu, A.,et al, 2015
Summary of Evidence-Based Guideline Update: Prevention of Stroke in Nonvalvular Atrial Fibrillation
Neurol 82:716-724, Culebras, A.,et al, 2014
Evaluation of Cryptogenic Stroke with Advanced Diagnostic Techniques
Stroke 45:1186-1194, Bang, O.Y.,et al, 2014
Diagnostic Yield of Pelvic Magnetic Resonance Venography in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 45:2324-2329, Liberman, A.L.,et al, 2014
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
NEJM 371:699-710, DeBaun, M.R.,et al, 2014
Aspirin for Acute Stroke of Unknown Etiology in Resourse-Limited Settings
Neurol 83:787-793, Berkowitz, A.L.,et al, 2014
Stroke and Cancer - A Complicated Relationship
J Neurol Transl Neurosci 2:1039-1051, Dearborn, J.L.,et al, 2014
An Index to Identify Stroke-Related vs Incidental Patent Foramen Ovale in Cryptogenic Stroke
Neurol 81:619-625,619, Kent, D.M.,et al, 2013
Patent Foramen Ovale and Cryptogenic Stroke
Stroke 44:2676-2678, Furlan, A.J. and Jauss, M., 2013
Evaluation of Patients for Paroxysmal Atrial Fibrillation after Ischemic Stroke
Stroke 44:e168-e170, Sundararajan, K.,et al, 2013
Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention
Stroke 43:422-431, Kitsios,G.D.,et al, 2012
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012
Cardiac Workup of Ischemic Stroke: Can We Improve Our Diagnostic Yield?
Stroke 40:2893-2898, Morris,J.G.,et al, 2009
Reliability of Aortic MRI at 3 Testla in Patients with Acute Cryptogenic Stroke
JNNP 79:540-546,489, Harloff,A.,et al, 2008
Therapeutic Strategies After Examination by Transesophageal Echocardiography in 503 Patients with Ischemic Stroke
Stroke 37:859-864, Harloff,A.,et al, 2006
Closure of Patent Foramen Ovale After Cryptogenic Stroke
Lancet 368:350-352, Wrle,J., 2006
Patent Foramen Ovale Closure Devices
JAMA 294:366-369, Maisel,W.H.&Laskey,W.K., 2005
Patent Foramen Ovale in Young Adults with Unexplained Stroke
NEJM 353:2361-2372, Kizer,J.R. &Devereux,R.B., 2005
Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm
Neurol 62:1042-1050, Messe,S.R.,et al, 2004
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Stroke as the First Manifestation of a Concealed Pancreatic Neoplasia
Rev Neurol 38:332-335, Perez-Lazaro,C.,et al, 2004
Cerebral Infarction in Young Adults
Neurol 50:890-894, Kittner,S.J.,et al, 1998
Surgical Closure of Patent Foramen Ovale in Cryptogenic Stroke Patients
Stroke 28:2376-2381, Homma,S.,et al, 1997
The Effect of Multiple Neuroimaging Studies on Classification, Treatment and Outcome of Acute Ischemic Stroke
Ann Int Med 124:21-26, Salerno,S.M.,et al, 1996
Transesophageal Echocardiography in Patients with Focal Cerebral Ischemia of Unknown Cause
Stroke 27:691-694, Rauh,G.,et al, 1996
Cerebral Infarction in Patients Aged 15 to 40 Years
Stroke 27:2016-2019, Neto,J.I.S.,et al, 1996
Ischemic Stroke in Young Adults
Arch Neurol 52:491-495, Adams,H.P.,et al, 1995
Paradoxical Embolism as a Cause of Ischemic Stroke of Uncertain Etiology:A Transcranial Doppler Sonographic Study
Stroke 25:771-775, Itoh,T.,et al, 1994
Transesophageal Echocardiography & Contrast-TCD in the Detection of a Patent Foramen Ovale:Experiences with 111 Pts
Neurol 44:1603-1606, Klotzsch,C.,et al, 1994
Patent Foramen Ovale as a Risk Factor for Cryptogenic Stroke
Ann Int Med 117:461-465, DiTullio,M.,et al, 1992